GORE TO HIGHLIGHT NEW CLINICAL EVIDENCE AND VASCULAR INNOVATIONS AT VEITHsymposium
Clinical presentations will feature advancements in aortic care and venous disease, alongside the introduction of the GORE® GUIDRA Steerable Sheath FLAGSTAFF, Ariz., Nov. 10, 2026 /PRNewswire/ -- W. L. Gore & Associates' medical business (Gore) will put its innovations and clinical...
Covered in this story
Call it yourself
No calls on $NOV yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on NOV →Dalsna Finance is currently tracking 143 stories mentioning NOV, the earliest published 7 Oct 2025.
Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.